Triaging Patients With Musculoskeletal Disorders Directly to Physiotherapists at Primary Health Care Clinics.

Musculoskeletal Disorders Clinical Trial

Official title:

The Effects of Triaging Patients With Musculoskeletal Disorders Directly to Physiotherapists at Primary Health Care Clinics: a Pilot Study and Randomized Controlled Trial.

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02218749
• Other study ID #: 148611
• Secondary ID: VGFOUGSB-421881
• Status: Terminated
• Phase: N/A
• Start date: August 2014
• Est. completion date: March 2019

Study information

• Verified date: April 2019
• Source: Göteborg University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether initial triaging to physiotherapists of patients with musculoskeletal disorders who seek health care from primary care clinics affects the patients health and/or health care utilization differently than initial consultation with a general practitioner.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 55
• Est. completion date: March 2019
• Est. primary completion date: March 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years to 67 Years

Eligibility

Inclusion Criteria:

• seeking primary care clinic for musculoskeletal disorder

• age 16-67 years

• speaks enough Swedish or English to understand the patient information and complete the questionnaires

• triage nurse judges it suitable to triage participant to physiotherapist

Exclusion Criteria:

• has received treatment at the clinic by physician or physiotherapist during the preceding month for the same problem

• seeking for chronic musculoskeletal disorder with unchanged symptoms the latest 3 months and for which the patient has already tried physiotherapy

• seeking for help with medical aids other than crutches

• is in need of home care

• has been included in the study earlier

Related Conditions & MeSH terms

• Disease
• Musculoskeletal Diseases
• Musculoskeletal Disorders

Intervention

Other:
• Initially triaged to physiotherapist

• Initially triaged to physician

Locations

Country	Name	City	State
Sweden	Närhälsan Biskopsgården Health centre	Gothenburg
Sweden	Närhälsan Eriksberg Health centre	Gothenburg
Sweden	Närhälsan Kyrkbyn Health centre	Gothenburg

Sponsors (2)

Lead Sponsor	Collaborator
Göteborg University	Närhälsan Primary care Research and Development

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of physician visits		1 year
Primary	Change in self-evaluated level of pain latest week (0-10 scale)		3 months
Secondary	Number of physiotherapist visits		1 year
Secondary	Number of days of sick-leave		1 year
Secondary	Number of referrals for external examinations and to specialists		1 year
Secondary	Changes in health-related quality of life measured with EQ-5D		2 weeks
Secondary	Changes in health-related quality of life measured with EQ-5D		3 months
Secondary	Changes in health-related quality of life measured with EQ-5D		6 months
Secondary	Changes in health-related quality of life measured with EQ-5D		1 year
Secondary	Changes in attitudes regarding responsibility for musculoskeletal disorders measured with ARM scale		2 weeks
Secondary	Changes in attitudes regarding responsibility for musculoskeletal disorders measured with ARM scale		3 months
Secondary	Changes in attitudes regarding responsibility for musculoskeletal disorders measured with ARM scale		6 months
Secondary	Changes in attitudes regarding responsibility for musculoskeletal disorders measured with ARM scale		1 year
Secondary	Change in experience of functional difficulty measured with DRI scale		2 weeks
Secondary	Change in experience of functional difficulty measured with DRI scale		3 months
Secondary	Change in experience of functional difficulty measured with DRI scale		6 months
Secondary	Change in experience of functional difficulty measured with DRI scale		1 year
Secondary	Risk for developing chronic pain measured with the Örebro Musculoskeletal Pain Screening Questionnaire		2 weeks
Secondary	Risk for developing chronic pain measured with the Örebro Musculoskeletal Pain Screening Questionnaire		3 months
Secondary	Risk for developing chronic pain measured with the Örebro Musculoskeletal Pain Screening Questionnaire		6 months
Secondary	Risk for developing chronic pain measured with the Örebro Musculoskeletal Pain Screening Questionnaire		1 year
Secondary	Change in self-evaluated level of pain latest week (0-10 scale)		2 weeks
Secondary	Change in self-evaluated level of pain latest week (0-10 scale)		6 months
Secondary	Change in self-evaluated level of pain latest week (0-10 scale)		1 year
Secondary	Prescriptions för analgesics for the actual musculoskeletal disorder	Received any prescriptions. Number of prescriptions. Number of occasions prescriptions were received. Type of prescription(s) received.	2 weeks
Secondary	Prescriptions för analgesics for the actual musculoskeletal disorder	Received any prescriptions. Number of prescriptions. Number of occasions prescriptions were received. Type of prescription(s) received.	3 months
Secondary	Prescriptions för analgesics for the actual musculoskeletal disorder	Received any prescriptions. Number of prescriptions. Number of occasions prescriptions were received. Type of prescription(s) received.	6 months
Secondary	Prescriptions för analgesics for the actual musculoskeletal disorder	Received any prescriptions. Number of prescriptions. Number of occasions prescriptions were received. Type of prescription(s) received.	1 year